Obesity, obesity-related metabolic conditions, and risk of thyroid cancer in women: results from a prospective cohort study (Sister Study)

被引:10
|
作者
Pasqual, Elisa [1 ]
O'Brien, Katie [2 ]
Rinaldi, Sabina [3 ]
Sandler, Dale P. [2 ]
Kitahara, Cari M. [1 ,4 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA
[2] NIEHS, Epidemiol Branch, Durham, NC USA
[3] Int Agcy Res Canc, 25 Ave Tony Garnier, CS 90627, F-69366 Lyon 07, France
[4] NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr, Rm 7E-456, Bethesda, MD 20892 USA
来源
基金
美国国家卫生研究院;
关键词
Thyroid cancer; Obesity; Obesity associated diseases; Diabetes; Risk factors; Epidemiology; POOLED ANALYSIS; ASSOCIATION; METFORMIN; BREAST;
D O I
10.1016/j.lana.2023.100537
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Thyroid cancer incidence has increased worldwide. Obesity trends may play a role, but the underlying biological pathways are not well-characterized. Therefore, we examined associations of excess adiposity and obesityrelated metabolic conditions with thyroid cancer incidence. Methods From the Sister Study, a cohort of sisters of women with breast cancer, we included 47,739 women who were cancer-free at baseline (2003-2009). Height, weight, waist and hip circumference, and blood pressure were measured at baseline and medical history was self-reported. Cox proportional hazards regression models were adjusted for age (time scale), race/ethnicity, smoking, baseline history of benign thyroid disease, and frequency of routine healthcare visits. Findings During follow-up (median = 12.5; max = 15.9 years), 259 women reported incident thyroid cancer. Body mass index (BMI) (hazard ratio [HR] (per-5 kg/m)2 = 1.25, 95% CI = 1.14-1.37), waist circumference (HRper- 5 cm increase = 1.11, 95% CI = 1.06-1.15), and waist-to-hip ratio (HR (>= 0.85-versus-<0.85) = 1.49, 95% CI = 1.14-1.94) were positively associated with thyroid cancer incidence, as were metabolic syndrome (HR = 1.67, 95% CI = 1.24-2.25), dyslipidemia (HR = 1.46, 95% CI = 1.13-1.90), borderline diabetes (HR = 2.06, 95% CI = 1.15-3.69), hypertension (HR = 1.49, 95% CI = 1.12-1.96), and polycystic ovary syndrome (PCOS, HR = 2.10, 95% CI = 1.20-3.67). These associations were attenuated with additional BMI adjustment, although dyslipidemia (HR = 1.35, 95% CI = 1.04-1.75) and PCOS (HR = 1.86, 95% CI = 1.06-3.28) remained associated with thyroid cancer incidence. Hypothyroidism was not associated with thyroid cancer. Interpretation In this cohort of sisters of women diagnosed with breast cancer, excess adiposity and several obesityrelated metabolic conditions were associated with thyroid cancer incidence. These findings provide insights into potential biological mechanisms linking obesity and thyroid cancer.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Metabolic obesity phenotypes and obesity-related cancer risk in the National Health and Nutrition Examination Survey
    Winn, Maci
    Karra, Prasoona
    Freisling, Heinz
    Gunter, Marc J. J.
    Haaland, Benjamin
    Litchman, Michelle L. L.
    Doherty, Jennifer A. A.
    Playdon, Mary C. C.
    Hardikar, Sheetal
    ENDOCRINOLOGY DIABETES & METABOLISM, 2023, 6 (04)
  • [22] Excess body weight, weight gain and obesity-related cancer risk in women in Norway: the Norwegian Women and Cancer study
    da Silva, Marisa
    Weiderpass, Elisabete
    Licaj, Idlir
    Lissner, Lauren
    Rylander, Charlotta
    BRITISH JOURNAL OF CANCER, 2018, 119 (05) : 646 - 656
  • [23] Common obesity-related anthropometric indices and the risk of gestational diabetes mellitus in a Chinese population: a prospective cohort study
    Wang, Hong
    Sui, Lun
    Xu, Qian
    Li, Minyu
    Xing, Yuhan
    Li, Guoju
    GYNECOLOGICAL ENDOCRINOLOGY, 2024, 40 (01)
  • [24] Metabolic syndrome and obesity-related cancer risk and survival: An umbrella review
    Winn, Maci
    Karra, Prasoona
    Benson, Ryzen
    Pauleck, Svenja
    Chaiyakunapruk, Nathorn
    Khaing, Win
    Casucci, Tallie
    McFarland, Mary M.
    Hu-Lieskovan, Siwen
    Litchman, Michelle
    Xu, Yizhe
    Playdon, Mary
    Hardikar, Sheetal
    CANCER RESEARCH, 2024, 84 (07)
  • [25] Obesity and AMD: Results from a prospective study of men and women
    Cote, J
    Rosner, B
    Seddon, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U411 - U411
  • [26] Obesity surgery and risk of colorectal and other obesity-related cancers: An English population-based cohort study
    Aravani, Ariadni
    Downing, Amy
    Thomas, James D.
    Lagergren, Jesper
    Morris, Eva J. A.
    Hull, Mark A.
    CANCER EPIDEMIOLOGY, 2018, 53 : 99 - 104
  • [27] Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study
    Sun, Ming
    Fritz, Josef
    Haggstrom, Christel
    Bjorge, Tone
    Nagel, Gabriele
    Manjer, Jonas
    Engeland, Anders
    Zitt, Emanuel
    van Guelpen, Bethany
    Stattin, Par
    Ulmer, Hanno
    Stocks, Tanja
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (04): : 456 - 467
  • [28] Transitions in metabolic syndrome and metabolic obesity status over time and risk of urologic cancer: A prospective cohort study
    Wang, Xia
    Jiang, Runxue
    Shen, Jianglun
    Chen, Shuohua
    Wu, Shouling
    Hu, Hailong
    Cai, Haifeng
    PLOS ONE, 2024, 19 (10):
  • [29] The effect of laparoscopic sleeve gastrectomy on morbid obesity and obesity-related comorbidities: A cohort study
    Cetinkunar, Suleyman
    Erdem, Hasan
    Aktimur, Recep
    Aziret, Mehmet
    Ozdas, Sabri
    Yurekli, Banu
    Yetisir, Fahri
    TURKISH JOURNAL OF SURGERY, 2015, 31 (04) : 202 - 206
  • [30] Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study
    Nystrom, Petter K.
    Carlsson, Axel C.
    Leander, Karin
    de Faire, Ulf
    Hellenius, Mai-Lis
    Gigante, Bruna
    PLOS ONE, 2015, 10 (05):